Demand for its TrueBeam radiation therapy system and x-ray tubes and flat-panel digital detectors contributed to revenue and earnings growth for radiation therapy firm Varian Medical Systems in its fiscal second quarter.
For the quarter (end-April 1), the vendor had revenues of $720 million, up 11% from the $648 million reported in the second quarter of fiscal 2011. Varian had net earnings of $108 million, compared with $103 million a year ago.
For the six-month period, Varian's revenues were $1.3 billion, up 7% from the $1.2 billion reported in the second quarter of fiscal 2011, with net earnings of $198 million compared with $200 million last year.
![A 53-year-old patient (patient number four) with a recurrent pituitary adenoma with extension of a cystic component of disease to the medial temporal lobe apparent on MRI (contoured in blue), and extension of disease to the left sphenoid bone and orbital apex apparent on [68Ga]Ga-DOTA-TATE (contoured in yellow).](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/04/pituitary-tumor.QGsEnyB4bU.jpg?auto=format%2Ccompress&fit=crop&h=100&q=70&w=100)
![A 53-year-old patient (patient number four) with a recurrent pituitary adenoma with extension of a cystic component of disease to the medial temporal lobe apparent on MRI (contoured in blue), and extension of disease to the left sphenoid bone and orbital apex apparent on [68Ga]Ga-DOTA-TATE (contoured in yellow).](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/04/pituitary-tumor.QGsEnyB4bU.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
